probenecid has been researched along with aztreonam in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deighton Fimls, R; Mohanty, KC; Strachan, RG | 1 |
| Imada, A; Kita, Y | 1 |
| Deighton, R; Mohanty, KC; Strachan, RG | 1 |
| Egger, HJ; Stoeckel, K; Weidekamm, E; Ziegler, WH | 1 |
| Frantz, M; Platt, TB; Stern, M; Sugerman, AA; Swabb, EA | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for probenecid and aztreonam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for probenecid and aztreonam
| Article | Year |
|---|---|
A comparative study of aztreonam and procaine penicillin/probenecid in the treatment of uncomplicated gonorrhoea.
Topics: Aztreonam; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Penicillin G; Penicillin G Procaine; Penicillinase; Probenecid; Random Allocation | 1988 |
Single intramuscular injection of aztreonam in the treatment of uncomplicated gonorrhoea in women.
Topics: Aztreonam; Drug Evaluation; Female; Gonorrhea; Humans; Injections, Intramuscular; Microbial Sensitivity Tests; Penicillin G; Probenecid | 1987 |
Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Clinical Trials as Topic; Dialysis; Feces; Half-Life; Humans; Kidney Glomerulus; Kinetics; Male; Probenecid; Protein Binding; Ultrafiltration | 1984 |
10 other study(ies) available for probenecid and aztreonam
| Article | Year |
|---|---|
Mechanism of renal excretion of carumonam in rats, rabbits, dogs, and monkeys.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Dogs; Female; Kidney; Lactams; Macaca fascicularis; Male; Metabolic Clearance Rate; Mice; Mice, Inbred ICR; Probenecid; Rabbits; Rats; Rats, Inbred Strains; Species Specificity | 1987 |
Renal handling of the monobactam azthreonam in healthy subjects.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Aztreonam; Glomerular Filtration Rate; Half-Life; Humans; Infusions, Parenteral; Inulin; Kidney; Kidney Tubules; Male; Probenecid; Protein Binding | 1983 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship | 2013 |